Filing Details
- Accession Number:
- 0001104659-24-071247
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-06-13 16:01:19
- Reporting Period:
- 2024-06-11
- Accepted Time:
- 2024-06-13 16:01:19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 872589 | Regeneron Pharmaceuticals Inc. | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1218629 | S Leonard Schleifer | 777 Old Saw Mill River Road Tarrytown NY 10591 | Bd. Co-Chair, President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-06-11 | 7,321 | $1,015.28 | 56,877 | No | 4 | S | Indirect | By Trust |
| Common Stock | Disposition | 2024-06-11 | 1,743 | $1,016.04 | 55,134 | No | 4 | S | Indirect | By Trust |
| Common Stock | Disposition | 2024-06-12 | 14,879 | $1,015.30 | 40,255 | No | 4 | S | Indirect | By Trust |
| Common Stock | Disposition | 2024-06-12 | 270 | $1,016.62 | 39,985 | No | 4 | S | Indirect | By Trust |
| Common Stock | Acquisiton | 2024-06-12 | 1,000 | $0.00 | 1,000 | No | 4 | C | Indirect | by Trust for Son |
| Common Stock | Disposition | 2024-06-12 | 1,000 | $1,025.27 | 0 | No | 4 | S | Indirect | by Trust for Son |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | By Trust |
| No | 4 | S | Indirect | By Trust |
| No | 4 | S | Indirect | By Trust |
| No | 4 | S | Indirect | By Trust |
| No | 4 | C | Indirect | by Trust for Son |
| No | 4 | S | Indirect | by Trust for Son |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Class A Stock | Disposition | 2024-06-12 | 1,000 | $0.00 | 1,000 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 14,775 | No | 4 | C | Indirect |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 157,552 | Indirect | 2023 GRAT |
| Common Stock | 5,932 | Indirect | By 401(k) Plan |
| Common Stock | 466,877 | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Class A Stock | $0.00 | 1,710,790 | 1,710,790 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 1,710,790 | 1,710,790 | Direct |
Footnotes
- Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 5, 2024.
- Represents volume-weighted average price of sales of 7,321 shares of common stock of Regeneron Pharmaceuticals, Inc. (the "Company") on June 11, 2024 at prices ranging from $1,015.00 to $1,015.85. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 11, 2024 at each separate price.
- Represents volume-weighted average price of sales of 1,743 shares of Company stock on June 11, 2024 at prices ranging from $1,016.04 to $1,016.10. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 11, 2024 at each separate price.
- Represents volume-weighted average price of sales of 14,879 shares of Company stock on June 12, 2024 at prices ranging from $1,015.00 to $1,015.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 12, 2024 at each separate price.
- Represents volume-weighted average price of sales of 270 shares of Company stock on June 12, 2024 at prices ranging from $1,016.10 to $1,016.80. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 12, 2024 at each separate price.
- Represents volume-weighted average price of sales of 1,000 shares of Company stock on June 12, 2024 at prices ranging from $1,025.00 to $1,025.55. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 12, 2024 at each separate price.
- Class A Stock of the Company converts to common stock of the Company on a one-to-one basis upon certain events or upon election of the shareholder.
- These shares of Class A Stock are presently convertible and such conversion feature does not expire.
Billionaire Hedge Funds
